RAC Vaccines and Vaccination Group

Primary tabs

Wed, 2021-01-13 11:16 — mdmcdonald

RAC Workgroup Efforts Focused on Vaccines and Vaccination

The Resilient American Communities (RAC) Vaccines and Vaccination Group is examining and acting on the issues surrounding vaccines development, distribution, vaccination logistics and execution, as well as vaccination strategy, safety, efficacy, trust, and hesitancy. Special attention is currently focused on COVID-19 vaccines and vaccination.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Hank Rappaport

Jan Booher

John Girard

Kathleen H

mdmcdonald

mike kraft

Subscribe to group

Email address for group

rac-vaccination@m.resiliencesystem.org

Emergency listing for Corbevax COVID vaccine approved by WHO

Tue, 2024-01-23 19:52 — mike kraft

WHO grants emergency listing for Corbevax COVID vaccine Non-exclusive licensing of the yeast strain by developers will allow others to develop effective, low-cost vaccines. CIDRAP

The World Health Organization (WHO) has approved another COVID-19 vaccine for emergency use listing (EUL): Corbevax, a recombinant protein–based vaccine developed by scientists at Texas Children's Hospital and Baylor College of Medicine.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Other

Read more about Emergency listing for Corbevax COVID vaccine approved by WHO
Log in or register to post comments

Analysis: How long immunity might last after a COVID infection

Tue, 2024-01-23 19:40 — mike kraft

How long does immunity last after a COVID infection? While some lucky people believe they’ve never had COVID, many are facing their second, third or even fourth infection. Here’s what the evidence shows. The Conversation

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Analysis: How long immunity might last after a COVID infection
Log in or register to post comments

Measeles: Alarming 45-fold rise in measles in Europe - WHO

Tue, 2024-01-23 17:57 — mike kraft

Alarming 45-fold rise in measles in Europe - WHO Urgent measures are needed now to stop further spread, the World Health Organization says. BBC News

There was an "alarming" nearly 45-fold increase in measles cases in Europe last year, the World Health Organization (WHO) says.

Health chiefs are warning that cases are still rising and "urgent measures" are needed to prevent further spread.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Measeles: Alarming 45-fold rise in measles in Europe - WHO
Log in or register to post comments

Study indicates how COVID-19 Vaccines and Infections Are Tweaking Our Immunity

Tue, 2024-01-23 09:06 — mike kraft

How COVID-19 Vaccines and Infections Are Tweaking Our Immunity A study shows our immune systems may be getting better at protecting against new variants. TIME

Your immune system may be getting smarter every time you encounter COVID-19, a new study suggests. After getting vaccinated and infected, the immune system generates broader defenses against the virus, including against new variants.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Study indicates how COVID-19 Vaccines and Infections Are Tweaking Our Immunity
Log in or register to post comments

Amid sharp increase in measle cases, UK officials urge millions of parents to get their kids vaccinated

Mon, 2024-01-22 17:51 — mike kraft

Millions in the UK are being urged to get vaccinations during a surge in measles cases U.K. health officials are urging millions of parents to book their children for missed measles, mumps and rubella shots during a sharp increase in the number of measles cases and the lowest vaccination rates in a decade. AP News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study

Mon, 2024-01-22 11:27 — mike kraft

Oral antiviral simnotrelvir shows promise for treating mild COVID-19 The length of COVID-19 symptoms was on average 36 hours shorter in the simnotrelvir group. CIDRAP

..in the New England Journal of Medicine Chinese researchers have published positive trial results of simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate COVID-19 symptoms.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study
Log in or register to post comments

First malaria vaccine program for children starts in Cameroon

Mon, 2024-01-22 10:10 — mike kraft

Cameroon starts world's first malaria vaccine program for children Cameroon will be the first country to routinely give children a new malaria vaccine as the shots are rolled out in Africa. AP News

Cameroon will be the first country to routinely give children a new malaria vaccine as the shots are rolled out in Africa.

The campaign due to start Monday was described by officials as a milestone in the decades-long effort to curb the mosquito-spread disease on the continent, which accounts for 95% of the world’s malaria deaths.

...

Country / Region Tags:

General Topic Tags: